These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 25860002)

  • 1. Immunogenicity of BCG in HIV-exposed and non-exposed infants following routine birth or delayed vaccination.
    Hesseling AC; Jaspan HB; Black GF; Nene N; Walzl G
    Int J Tuberc Lung Dis; 2015 Apr; 19(4):454-62. PubMed ID: 25860002
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Safety and Immunogenicity of Newborn MVA85A Vaccination and Selective, Delayed Bacille Calmette-Guerin for Infants of Human Immunodeficiency Virus-Infected Mothers: A Phase 2 Randomized, Controlled Trial.
    Nemes E; Hesseling AC; Tameris M; Mauff K; Downing K; Mulenga H; Rose P; van der Zalm M; Mbaba S; Van As D; Hanekom WA; Walzl G; Scriba TJ; McShane H; Hatherill M;
    Clin Infect Dis; 2018 Feb; 66(4):554-563. PubMed ID: 29028973
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The impact of HIV exposure and maternal Mycobacterium tuberculosis infection on infant immune responses to bacille Calmette-Guérin vaccination.
    Jones CE; Hesseling AC; Tena-Coki NG; Scriba TJ; Chegou NN; Kidd M; Wilkinson RJ; Kampmann B
    AIDS; 2015 Jan; 29(2):155-65. PubMed ID: 25535752
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunogenicity and safety of early vs delayed BCG vaccination in moderately preterm (31-33 weeks) infants.
    Saroha M; Faridi MM; Batra P; Kaur I; Dewan DK
    Hum Vaccin Immunother; 2015; 11(12):2864-71. PubMed ID: 26431252
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Population differences in immune responses to Bacille Calmette-Guérin vaccination in infancy.
    Lalor MK; Ben-Smith A; Gorak-Stolinska P; Weir RE; Floyd S; Blitz R; Mvula H; Newport MJ; Branson K; McGrath N; Crampin AC; Fine PE; Dockrell HM
    J Infect Dis; 2009 Mar; 199(6):795-800. PubMed ID: 19434928
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Early versus late BCG vaccination in HIV-1-exposed infants in Uganda: study protocol for a randomized controlled trial.
    Nankabirwa V; Tumwine JK; Namugga O; Tylleskär T; Ndeezi G; Robberstad B; Netea MG; Sommerfelt H
    Trials; 2017 Mar; 18(1):152. PubMed ID: 28359325
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Natural variation in immune responses to neonatal Mycobacterium bovis Bacillus Calmette-Guerin (BCG) Vaccination in a Cohort of Gambian infants.
    Finan C; Ota MO; Marchant A; Newport MJ
    PLoS One; 2008; 3(10):e3485. PubMed ID: 18941532
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Delaying BCG vaccination until 8 weeks of age results in robust BCG-specific T-cell responses in HIV-exposed infants.
    Tchakoute CT; Hesseling AC; Kidzeru EB; Gamieldien H; Passmore JA; Jones CE; Gray CM; Sodora DL; Jaspan HB
    J Infect Dis; 2015 Feb; 211(3):338-46. PubMed ID: 25108027
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Persistence of the immune response induced by BCG vaccination.
    Weir RE; Gorak-Stolinska P; Floyd S; Lalor MK; Stenson S; Branson K; Blitz R; Ben-Smith A; Fine PE; Dockrell HM
    BMC Infect Dis; 2008 Jan; 8():9. PubMed ID: 18221509
    [TBL] [Abstract][Full Text] [Related]  

  • 10. BCG vaccination induces HIV target cell activation in HIV-exposed infants in a randomized trial.
    Gasper MA; Hesseling AC; Mohar I; Myer L; Azenkot T; Passmore JS; Hanekom W; Cotton MF; Crispe IN; Sodora DL; Jaspan HB
    JCI Insight; 2017 Apr; 2(7):e91963. PubMed ID: 28405623
    [No Abstract]   [Full Text] [Related]  

  • 11. Factors associated with tuberculosis infection, and with anti-mycobacterial immune responses, among five year olds BCG-immunised at birth in Entebbe, Uganda.
    Lule SA; Mawa PA; Nkurunungi G; Nampijja M; Kizito D; Akello F; Muhangi L; Elliott AM; Webb EL
    Vaccine; 2015 Feb; 33(6):796-804. PubMed ID: 25529292
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gamma interferon production in response to Mycobacterium bovis BCG and Mycobacterium tuberculosis antigens in infants born to human immunodeficiency virus-infected mothers.
    Van Rie A; Madhi SA; Heera JR; Meddows-Taylor S; Wendelboe AM; Anthony F; Violari A; Tiemessen CT
    Clin Vaccine Immunol; 2006 Feb; 13(2):246-52. PubMed ID: 16467333
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Delayed BCG vaccination results in minimal alterations in T cell immunogenicity of acellular pertussis and tetanus immunizations in HIV-exposed infants.
    Blakney AK; Tchakoute CT; Hesseling AC; Kidzeru EB; Jones CE; Passmore JA; Sodora DL; Gray CM; Jaspan HB
    Vaccine; 2015 Sep; 33(38):4782-9. PubMed ID: 26259542
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immune Responses Following BCG Immunization of Infants in Uganda and United Kingdom Are Similar for Purified Protein Derivative but Differ for Secretory Proteins of
    Mawa PA; Hasso-Agopsowicz M; Lubyayi L; Nabakooza G; Nakibuule M; Blitz R; Dun L; Govind A; Kaleebu P; Webb EL; Elliott AM; Dockrell HM; Cose S; Smith SG
    Front Immunol; 2021; 12():637114. PubMed ID: 33815390
    [No Abstract]   [Full Text] [Related]  

  • 15. Live-attenuated Mycobacterium tuberculosis vaccine MTBVAC versus BCG in adults and neonates: a randomised controlled, double-blind dose-escalation trial.
    Tameris M; Mearns H; Penn-Nicholson A; Gregg Y; Bilek N; Mabwe S; Geldenhuys H; Shenje J; Luabeya AKK; Murillo I; Doce J; Aguilo N; Marinova D; Puentes E; Rodríguez E; Gonzalo-Asensio J; Fritzell B; Thole J; Martin C; Scriba TJ; Hatherill M;
    Lancet Respir Med; 2019 Sep; 7(9):757-770. PubMed ID: 31416768
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Delayed BCG immunization does not alter antibody responses to EPI vaccines in HIV-exposed and -unexposed South African infants.
    Hesseling AC; Blakney AK; Jones CE; Esser MM; de Beer C; Kuhn L; Cotton MF; Jaspan HB
    Vaccine; 2016 Jul; 34(32):3702-9. PubMed ID: 27055019
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immune responses of white-tailed deer (Odocoileus virginianus) to Mycobacterium bovis BCG vaccination.
    Waters WR; Palmer MV; Whipple DL; Slaughter RE; Jones SL
    J Wildl Dis; 2004 Jan; 40(1):66-78. PubMed ID: 15137490
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diagnosis of latent tuberculosis infection in bacille Calmette-Guérin vaccinated subjects in China by interferon-gamma ELISpot assay.
    Zhang M; Wang H; Liao M; Chen X; Graner M; Zhu X; Zhang J; Yang Q; Lu H; Zhou B; Chen X
    Int J Tuberc Lung Dis; 2010 Dec; 14(12):1556-63. PubMed ID: 21144240
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High-sensitive and rapid detection of Mycobacterium tuberculosis infection by IFN-gamma release assay among HIV-infected individuals in BCG-vaccinated area.
    Jiang W; Shao L; Zhang Y; Zhang S; Meng C; Xu Y; Huang L; Wang Y; Wang Y; Weng X; Zhang W
    BMC Immunol; 2009 May; 10():31. PubMed ID: 19476627
    [TBL] [Abstract][Full Text] [Related]  

  • 20. BCG-induced increase in interferon-gamma response to mycobacterial antigens and efficacy of BCG vaccination in Malawi and the UK: two randomised controlled studies.
    Black GF; Weir RE; Floyd S; Bliss L; Warndorff DK; Crampin AC; Ngwira B; Sichali L; Nazareth B; Blackwell JM; Branson K; Chaguluka SD; Donovan L; Jarman E; King E; Fine PE; Dockrell HM
    Lancet; 2002 Apr; 359(9315):1393-401. PubMed ID: 11978337
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.